FARRELL PETER C 4
4 · RESMED INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
RESMED INCRMD
FARRELL PETER C
Director
Transactions
- Sale
ResMed Common Stock
[F1]2026-03-04$260.22/sh−2,000$520,440→ 62,773 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
Signature
/s/ Peter C. Farrell, Chairman emeritus|2026-03-05